XWPharma

Venture capital investment in biopharmaceutical companies has been remarkable throughout 2020, both in terms of individual company fundraisings and new VC funds, including two funds totaling $755m tha

China gene-editing startup EdiGene has appointed Yun Li , MD, as vice president of clinical development. Li has more than 20 years' experience in clinical development of novel therapeutics, mainly

Innovation is undoubtedly the key element in China’s healthcare investment scenario and early-stage venture capital funds continue to back home-grown new drug development with a total of 15 deals in t

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar